Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
We have cloned a member of the steroid hormone receptor superfamily of ligand-activated transcription factors. The receptor homologue is activated by a diverse class of rodent hepatocarcinogens that causes proliferation of peroxisomes. Identification of a peroxisome proliferator-activated receptor should help elucidate the mechanism of the hypolipidaemic effect of these hepatocarcinogens and aid evaluation of their potential carcinogenic risk to man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After the structure of PPAR was clarified, three PPAR isoforms (PPARα, PPARγ, and PPARδ) have been identified, each of which is encoded by a separate gene [21].”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [21]
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,087
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
Self-citationA human retinoic acid receptor which belongs to the family of nuclear receptors
Petkovich, M., Brand, N. J., Krust, A., & Chambon, P. (1987) · Nature · doi:10.1038/330444a0 · Cited by 2,214
Identification of a receptor for the morphogen retinoic acid
Giguere, V., Ong, E. S., Segui, P., & Evans, R. M. (1987) · Nature · doi:10.1038/330624a0 · Cited by 1,965
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
The c-erb-A gene encodes a thyroid hormone receptor
Weinberger, C., Thompson, C. C., Ong, E. S., Lebo, R., Gruol, D. J., & Evans, R. M. (1986) · Nature · doi:10.1038/324641a0 · Cited by 1,477
Functional domains of the human estrogen receptor
Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., & Chambon, P. (1987) · Cell · doi:10.1016/0092-8674(87)90581-2 · Cited by 1,316
Self-citation
Research works printed but not linked: 8
- Reddy, J. K., Rao, M. S., Azarnoff, D. I. & Sell, S. Cancer Res. 39, 152–161 (1979).
- Sirtori, C. R., Catapano, A. & Paoletti, R. Atherosclerosis Rev. 2, 113–153 (1977).
- Warren, J. R., Simmon, V. F. & Reddy, J. K. Cancer Res. 40, 36–41 (1980).
- Kasai, H., Okadi, Y., Nishimura, S., Rao, M. S. & Reddy, J. K. Cancer Res. 49, 2603–2605 (1989).
- Marsman, D. S., Cattley, R. C., Conway, J. G. & Popp, J. A. Cancer Res. 48, 6739–6744 (1988).
- Cattley, R. C. & Popp, J. A. Cancer Res. 49, 3246–3251 (1989).
- Nemali, M. R. et al. Cancer Res. 48, 5316–5324 (1988).
- Current Protocols in Molecular Biology (Wiley, New York, 1990).
Cited by
Items 801–900 of 1,011
Anti-apoptotic Actions of PPAR-γ Against Ischemic Stroke
Fong, W.-H., Tsai, H., Chen, Y.-C., Wu, J., & Lin, T. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8103-y · Cited by 93
“PPAR was originally cloned from liver peroxisomes, organelles that participate in fatty acid metabolism [2].”
BackgroundRegulation of Intestinal Inflammation by Dietary Fats
Basson, A. R., Chen, C., Sagl, F., Trotter, A., Bederman, I. R., Gomez-Nguyen, A., Sundrud, M. S., Ilić, S., Cominelli, F., & Rodriguez‐Palacios, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604989 · Cited by 96
Cheng, H. S., Yip, Y. S., Lim, K. Y., Wahli, W., & Tan, N. S. (2021) · Cancers · doi:10.3390/cancers13092153 · Cited by 90
“In 1990, the first isotype of PPAR, now called PPARα, was successfully cloned from the mouse liver and identified as a novel nuclear receptor that is essential for triglyceride and cholesterol homeostasis [1].”
BackgroundReview: PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury
Collino, M., Patel, N. S. A., & Thiemermann, C. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708090924 · Cited by 86
Xenobiotic-Activated Receptors: From Transcription to Drug Metabolism to Disease
Ma, Q. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800156s · Cited by 92
Tugwood, J. D., Holden, P. R., James, N. H., Prince, R. A., & Roberts, R. A. (1998) · Archives of Toxicology · doi:10.1007/s002040050483 · Cited by 87
“Initially isolated from mouse (Issemann and Green 1990), this receptor is highly expressed in rat and mouse liver (Issemann and Green 1990; Kliewer et al.”
BackgroundPlutzky, J. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0067-3 · Cited by 89
Perturbation of the Mitosis/Apoptosis Balance: A Fundamental Mechanism in Toxicology,
Roberts, R. A. (1997) · Fundamental and Applied Toxicology · doi:10.1006/faat.1997.2331 · Cited by 87
Qi, J.-S., Desai-Yajnik, V., Greene, M. E., Raaka, B. M., & Samuels, H. H. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1817 · Cited by 87
“Other members of this subfamily include the 1,25-dihydroxyvitamin D3 (Vit D) receptor (VDR) (2, 32, 46), receptors which mediate the peroxisomal proliferation response to fatty acids and other factors (PPARs) (18, 33, 36, 38), and several orphan receptors for which ligands are either unknown or not required for activi…”
BackgroundMethodInfluentialOkabe, T., Haji, M., Takayanagi, R., Adachi, M., Imasaki, K., Kurimoto, F., Watanabe, T., & Nawata, H. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.10.7559886 · Cited by 97
Duszka, K., Gregor, A., Guillou, H., König, J. S., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071708 · Cited by 90
“The first cloned PPAR, now known as PPARα, was initially identified as the molecular target of xenobiotics inducing hepatic peroxisome proliferation in rodents [44].”
BackgroundReka, A. K., Goswami, M. T., Krishnapuram, R., Standiford, T. J., & Keshamouni, V. G. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.01.019 · Cited by 91
“To date, three isotypes of PPARs called PPAR-α, PPAR-γ and PPAR-δ have been identified [8,9].”
BackgroundBoitier, E., Gautier, J.-C., & Roberts, R. (2003) · Comparative Hepatology · doi:10.1186/1476-5926-2-3 · Cited by 85
“dustrial compounds [37].”
Xu, D., Murakoshi, N., Igarashi, M., Hirayama, A., Ito, Y., Seo, Y., Tada, H., & Aonuma, K. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02186.x · Cited by 87
The impact of PPARα activation on whole genome gene expression in human precision cut liver slices
Janssen, A. W. F., Betzel, B., Stoopen, G., Berends, F. J., Janssen, I. M., Peijnenburg, A. A., & Kersten, S. (2015) · BMC Genomics · doi:10.1186/s12864-015-1969-3 · Cited by 84
“In addition, PPARα serves as receptor for a diverse array of synthetic compounds collectively referred to as peroxisome proliferators [17].”
BackgroundCytochrome P450-dependent fatty acid hydroxylases in plants
Kandel, S. E., Sauveplane, V., Olry, A., Diss, L., Benveniste, I., & Pinot, F. (2006) · Phytochemistry Reviews · doi:10.1007/s11101-006-9041-1 · Cited by 85
Kuo, M. T., & Savaraj, N. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20240 · Cited by 88
“A receptor-based activationmechanismmediatedbyPPARa, PPARb/d, and PPARg is involved in such a diverse group of compounds to PPARs [20].”
BackgroundKostiuk, M. A., Keller, B. O., & Berthiaume, L. G. (2010) · The FASEB Journal · doi:10.1096/fj.09-149765 · Cited by 85
“that are ligand-activated transcription factors belonging to the nuclear receptor superfamily (10, 11).”
BackgroundPola, R., Gaetani, E., Flex, A., Aprahamian, T. R., Bosch-Marcé, M., Losordo, D. W., Smith, R. C., & Pola, P. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.10.016 · Cited by 89
“In addition to this classical signaling pathway, PGI2 also utilizes a class of nuclear receptors known as peroxisome proliferator-activated receptors (PPARs), that belong to a family of ligand-activated transcription factors with activities relevant to broad aspects of cardiovascular biology [8–16].”
BackgroundHerrmann, S.-M., Ringel, J., Wang, J., Staessen, J. A., & Brand, E. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2653 · Cited by 89
“PPAR- 2, expressed in vascular smooth muscle cells, mesangial cells, and macrophages, is a ligand-activated transcription factor and a member of the steroid receptor superfamily (11), which has been shown to be involved in lipid and glucose metabolism, fatty acid transport, and cell differentiation (12).”
Quintão, N. L. M., Santin, J. R., Stoeberl, L. C., Corrêa, T. P., Melato, J., & da Costa, R. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00907 · Cited by 95
“PPARs were originally identified in 1990 with the first cloning (PPARα) happening during molecular targeting for peroxisome proliferating agents in rodents (Issemann and Green, 1990).”
BackgroundLess Extrahepatic Induction of Fatty Acid β-Oxidation Enzymes by PPARα
Cook, W. S., Yeldandi, A. V., Rao, M. S., Hashimoto, T., & Reddy, J. K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3739 · Cited by 90
Cheema, S. K., & Agellon, L. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12530 · Cited by 85
Mandard, S., & Patsouris, D. (2013) · PPAR Research · doi:10.1155/2013/613864 · Cited by 90
Brusotti, G., Montanari, R., Capelli, D., Cattaneo, G., Laghezza, A., Tortorella, P., Loiodice, F., Peiretti, F., Bonardo, B., Paiardini, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05666-6 · Cited by 87
PPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic Patients
Lange, N. F., Graf, V., Caussy, C., & Dufour, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084305 · Cited by 96
“Fibrates were the first drug class utilizing PPARα agonism, albeit unknowingly, until discovery of the nuclear receptor [22].”
Kamijo‐Ikemori, A., Sugaya, T., Obama, A., Hiroi, J., Miura, H., Watanabe, M., Kumai, T., Ohtani‐Kaneko, R., Hirata, K., & Kimura, K. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060131 · Cited by 85
Identification and characterization of PPARα ligands in the hippocampus
Roy, A., Kundu, M., Jana, M., Mishra, R. K., Yung, Y., Luan, C.-H., Gonzalez, F. J., & Pahan, K. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2204 · Cited by 82
“Peroxisome proliferator-activated receptor α (PPAR α ) belongs to a class of nuclear hormone receptors 1 that participates in a diverse range of biological functions including control of fatty acid transport and catabolism 2 , anti-inflammation 3 , immuno-modulation 4 , and anti-oxidation 5 .”
Mahmoudvand, S., Shokri, S., Taherkhani, R., & Farshadpour, F. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i1.42 · Cited by 89
Endocrine disrupters in the aquatic environment
Stahlschmidt‐Allner, P., Allner, B., Römbke, J., & Knacker, T. (1997) · Environmental Science and Pollution Research · doi:10.1007/bf02986325 · Cited by 84
The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling
Desvergne, B., Ijpenberg, A., Devchand, P. R., & Wahli, W. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00182-9 · Cited by 83
PPARγSignaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung
Rehan, V. K., & Torday, J. S. (2012) · PPAR Research · doi:10.1155/2012/289867 · Cited by 87
“In the early 1990s,based on sequence homology with previously identified members of nuclear hormone receptor superfamily, three PPAR isotypes (PPARα, β/δ, and γ) were identified, initially in Xenopus laevis and the mouse, and later in human, rat, fish, hamster, and chicken [72, 73].”
BackgroundDongol, B., Shah, Y. M., Kim, I., Gonzalez, F. J., & Hunt, M. C. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700119-jlr200 · Cited by 90
“Green (1), which at that time was shown to be activated by peroxisome proliferators.”
BackgroundQuantitative weight of evidence to assess confidence in potential modes of action
Becker, R. A., Dellarco, V. L., Seed, J. G., Kronenberg, J. M., Meek, B., Foreman, J. E., Palermo, C. M., Kirman, C. R., Linkov, I., Schoeny, R. S., et al. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.02.017 · Cited by 84
Prentice, D., & Meikle, A. (1995) · Human & Experimental Toxicology · doi:10.1177/096032719501400703 · Cited by 80
The peroxisome proliferator-activated receptor interacts with the retinoid X receptor in vivo
Miyata, K., McCaw, S. E., Marcus, S. L., Rachubinski, R. A., & Capone, J. P. (1994) · Gene · doi:10.1016/0378-1119(94)90707-2 · Cited by 83
Transcriptional Suppression of the Transferrin Gene by Hypolipidemic Peroxisome Proliferators
Hertz, R., Seckbach, M., Zakin, M. M., & Bar-Tana, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.218 · Cited by 85
Patel, D. D., Knight, B. L., Soutar, A. K., Gibbons, G. F., & Wade, D. P. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510747 · Cited by 83
Jow, L., & Mukherjee, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3836 · Cited by 83
Peroxisome Proliferator-activated Receptor α Inhibits Hepatic S14 Gene Transcription
Ren, B., Thelen, A., & Jump, D. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17167 · Cited by 84
Thiazolidinedione-Induced Fluid Retention Is Independent of Collecting Duct αENaC Activity
Vallon, V., Hümmler, E., Rieg, T., Pochynyuk, O. M., Bugaj, V., Schroth, J., Dechênes, G., Rossier, B. C., Cunard, R. A., & Stockand, J. D. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008040415 · Cited by 87
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
Vella, V., Nicolosi, M. L., Giuliano, S., Bellomo, M., Belfiore, A., & Malaguarnera, R. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00031 · Cited by 91
“The name derives from the first identified member that belongs to a group of hepatocarcinogens that upregulate the proliferation of peroxisomes (62).”
BackgroundYang, F., Zhang, Z., Xin, D., Shi, C.-J., Wu, J., Guo, Y., & Guan, Y. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00753.x · Cited by 82
Kruszynska, Y. T., Mukherjee, R., Jow, L., Dana, S., Paterniti, J. R., & Olefsky, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1076 · Cited by 83
Iwakiri, Y., Sampson, D. A., & Allen, K. G. D. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2002.0454 · Cited by 82
Rolfe, M. (1997) · Carcinogenesis · doi:10.1093/carcin/18.11.2277 · Cited by 83
“The molecular mechanisms of the putative TNFα production or release in response to PPs are unclear at present but since PPs activate a transcription factor, the peroxisome proliferator activated receptor alpha (PPARα) ( 38 ,39), it is probable that the transcription of new genes modulates the observed perturbation of…”
BackgroundPoellinger, L., Göttlicher, M., & Gustafsson, J.-Α. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90076-i · Cited by 85
Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis
Kaplan, J. M., Nowell, M., Chima, R. S., & Zingarelli, B. (2013) · Innate Immunity · doi:10.1177/1753425913501565 · Cited by 85
“Although PPARs were initially described as important in triglyceride and cholesterol homeostasis these receptors are also important in regulating the inflammatory response.(31) PPARg can trans-activate and trans-repress target genes through ligand-dependent and ligand-independent mechanisms.”
BackgroundYap, K. M., Sekar, M., Seow, L.-J., Gan, S. H., Bonam, S. R., Rani, N. N. I. M., Lum, P. T., Subramaniyan, V., Wu, Y. S., Fuloria, N. K., et al. (2021) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s316667 · Cited by 101
PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales
Colapietro, F., Gershwin, M. E., & Lleo, A. (2023) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2023.100188 · Cited by 75
“PPARs are nuclear receptors first identified and cloned in 1990, with a key role in regulation of transcription of genes involved in inflammation, carcinogenesis, and metabolic pathways [10].”
BackgroundThe Roles of Peroxisome Proliferator-Activated Receptors in the Metabolic Syndrome
Mansour, M. M. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00007-7 · Cited by 83
Cristiano, L., Bernardo, A., & Ceru`, M. P. (2001) · Journal of Neurocytology · doi:10.1023/a:1016525716209 · Cited by 88
Peroxisome proliferator-activated receptors A link between endocrinology and nutrition?
Keller, H., & Wahli, W. (1993) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(93)90048-j · Cited by 85
Edvardsson, U., von Löwenhielm, H. B., Panfilov, O., Nyström, A., Nilsson, F. Y., & Dahllöf, B. (2003) · PROTEOMICS · doi:10.1002/pmic.200390061 · Cited by 82
Peroxisome Proliferator-Activated Receptor α Antagonism Inhibits Hepatitis C Virus Replication
Rakić, B., Sagan, S. M., Noestheden, M. R., Bélanger, S., Nan, X., Evans, C. L., Xie, X. S., & Pezacki, J. P. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.10.006 · Cited by 86
“Peroxisome proliferator-activated receptors (PPARs) play an important role in controlling gene expression of lipid metabolism [19].”
BackgroundControl of adipogenesis by oxylipins, GPCRs and PPARs
Barquissau, V., Ghandour, R. A., Ailhaud, G. P., Klingenspor, M., Langin, D., Amri, E., & Pisani, D. F. (2016) · Biochimie · doi:10.1016/j.biochi.2016.12.012 · Cited by 83
“(NR1C1) was the first subtype to be identified in the early 1990s when its ligands were found to induce peroxisome proliferation [22].”
BackgroundMalerød, L., Sporstøl, M., Juvet, L. K., Mousavi, A., Gjøen, T., & Berg, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00819-2 · Cited by 89
Regulation by fatty acids of angiotensinogen gene expression in preadipose cells
SAFONOVA, I., AUBERT, J., NEGREL, R., & AILHAUD, G. (1997) · Biochemical Journal · doi:10.1042/bj3220235 · Cited by 83
Duke, K. S., & Bonner, J. C. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1498 · Cited by 88
Li, P., Oyang, X., Xie, X., Guo, Y., Li, Z., Xi, J., Zhu, D., Ma, X., Liu, B., Li, J., et al. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2019.113512 · Cited by 81
Role of Myc in hepatocellular proliferation and hepatocarcinogenesis
Qu, A., Jiang, C., Cai, Y., Kim, J.-H., Tanaka, N., Ward, J. M., Shah, Y. M., & Gonzalez, F. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.024 · Cited by 80
“Fibrate drugs used to lower plasma triglycerides [26], are agonist for PPARa, a ligand-activated nuclear receptor that controls genes involved in fatty acid transport and catabolism, primarily in liver, but also in kidney, heart and skeletal muscle [27,28].”
URINARY LIVER-TYPE FATTY ACID-BINDING PROTEIN IN SEPTIC SHOCK
Nakamura, T., Sugaya, T., & Koide, H. (2009) · Shock · doi:10.1097/shk.0b013e3181891131 · Cited by 80
“Liver-type fatty acidYbinding protein transports free fatty acids from the cytosol to the nucleus (21) and interacts with the nuclear protein, peroxisome proliferatorYactivated receptor, which is a nuclear target for free fatty acids and initiates gene expression of enzymes involved in lipid metabolism (22, 23).”
BackgroundPilot trial: Pioglitazone versus placebo in patients with plaque psoriasis (the P6)
Shafiq, N., Malhotra, S., Pandhi, P., Gupta, M., Kumar, B., & Sandhu, K. (2005) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2005.02504.x · Cited by 79
PPARγ and metabolism: insights from the study of human genetic variants
Gurnell, M. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01767.x · Cited by 89
“The name PPAR derives from the original observation that a structurally diverse array of compounds, which activate PPAR α , the first member of the family to be cloned, also increase the size and number of peroxisomes in rodent liver (Issemann & Green, 1990).”
Peroxisome Proliferator‐Activated Receptor β/δ in the Brain: Facts and Hypothesis
Hall, M. G., Quignodon, L., & Desvergne, B. (2008) · PPAR Research · doi:10.1155/2008/780452 · Cited by 79
“They are known as PPARα (NR1C1), PPARβ (NR1C2) also named PPARδ , and PPARγ (NR1C3) [8, 9].”
BackgroundLatruffe, N., Cherkaoui‐Malki, M., Nicolas-Francès, V., Clémencet, M.-C., Jannin, B., & Berlot, J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00416-0 · Cited by 80
Aperlo, C., Pognonec, P., Saladin, R., Auwerx, J. H., & Boulukos, K. E. (1995) · Gene · doi:10.1016/0378-1119(95)00196-d · Cited by 80
The PPAR–microbiota–metabolic organ trilogy to fine‐tune physiology
Oh, H. Y. P., Visvalingam, V., & Wahli, W. (2019) · The FASEB Journal · doi:10.1096/fj.201802681rr · Cited by 85
“Peroxisomeproliferators refer to a group of chemicals such as industrial plasticizers, herbicides, and also hypolipidemic drugs (like clofibrate) that cause an increase in hepatic peroxisomes and liver hyperplasia in rodents, specifically (76).”
BackgroundTranscriptional Regulation of Hepatic Fatty Acid Metabolism
Guillou, H., Martin, P. G. P., & Pineau, T. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_1 · Cited by 90
“One of the key transcriptional regulators of fatty acid catabolism which has been well characterized since its discovery in 1990 (Issemann and Green, 1990) is the nuclear receptor PPARa (Peroxisome Proliferator-Activated Receptor a).”
BackgroundCross‐Talk between PPARs and the Partners of RXR: A Molecular Perspective
Chan, L. S. A., & Wells, R. A. (2009) · PPAR Research · doi:10.1155/2009/925309 · Cited by 79
“Over 1000 papers have been published on the PPARs since their cloning in 1990 [1].”
BackgroundTakayanagi, K., Morimoto, S.-I., Shirakura, Y., Mukai, K., Sugiyama, T., Tokuji, Y., & Ohnishi, M. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf202821u · Cited by 79
Peroxisome Proliferator-Activated Receptor .GAMMA. and Cardiovascular Diseases
Takano, H., & Komuro, I. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1071 · Cited by 89
Differential expression of chicken hepatic genes responsive to PFOA and PFOS
Yeung, L. W. Y., Guruge, K. S., Yamanaka, N., Miyazaki, S., & Lam, P. K. S. (2007) · Toxicology · doi:10.1016/j.tox.2007.05.004 · Cited by 85
Peroxisomal Impairment in Niemann-Pick Type C Disease
Schedin, S., Sindelar, P. J., Pentchev, P., Brunk, U., & Dallner, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6245 · Cited by 80
Novel Euglycemic and Hypolipidemic Agents. 1
Lohray, B. B., Bhushan, V., Rao, B. P., Madhavan, G. R., Nagabelli, M., Rao, K. N., Reddy, A. K., Rajesh, B. M., Reddy, P. G., Chakrabarti, R., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970444e · Cited by 79
Shi, G. Q., Dropinski, J. F., McKeever, B. M., Xu, S., Becker, J. W., Berger, J. P., MacNaul, K. L., Elbrecht, A., Zhou, G., Doebber, T. W., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0502135 · Cited by 87
Fanelli, F., Sepe, S., D’Amelio, M., Bernardi, C., Cristiano, L., Cimini, A., Cecconi, F., Ceru', M. P., & Moreno, S. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-8 · Cited by 76
“Among these, we studied PPARα which is directly involved in peroxisomal induction [27],”
BackgroundArakawa, R., Tamehiro, N., Nishimaki-Mogami, T., Ueda, K., & Yokoyama, S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000163844.07815.c4 · Cited by 78
Thia fatty acids, metabolism and metabolic effects
Skrede, S., Sørensen, H. N., Larsen, L. N., Steineger, H. H., Høvik, K. E., Spydevold, Ø. S., Horn, R. S., & Bremer, J. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(96)00138-5 · Cited by 79
Inhibition of Peroxisome Proliferator Signaling Pathways by Thyroid Hormone Receptor
Miyamoto, T., Kaneko, A., Kakizawa, T., Yajima, H., Kamijo, K., Sekine, R., Hiramatsu, K., Nishii, Y., Hashimoto, T., & Hashizume, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7752 · Cited by 86
Cheon, Y., Nara, T. Y., Band, M. R., Beever, J. E., Wallig, M. A., & Nakamura, M. T. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00751.2004 · Cited by 77
“A standard SYBR Green Assay program for thermal cycling was used: 5 s at 95°C for one cycle and 40 cycles at 95°C for 15 s followed by 1 min at 60°C.”
BackgroundInfluentialStaels, B., Schoonjans, K., Fruchart, J., & Auwerx, J. H. (1997) · Biochimie · doi:10.1016/s0300-9084(97)81497-6 · Cited by 89
Leaver, M. J., Wright, J., & George, S. G. (1997) · Biochemical Journal · doi:10.1042/bj3210405 · Cited by 86
Asano, T., Wakisaka, M., Yoshinari, M., Iino, K., Sonoki, K., Iwase, M., & Fujishima, M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00054-9 · Cited by 84
Jones, P. S., Savory, R., Barratt, P., Bell, A. R., Gray, T. J. B., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., & Bell, D. R. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.219_1.x · Cited by 78
Hasmall, S. C., James, N. H., Macdonald, N., Soames, A. R., & Roberts, R. A. (2000) · Archives of Toxicology · doi:10.1007/s002040050657 · Cited by 78
“PPs activate peroxisome proliferator activated receptor a (PPARa) (Issemann and Green 1990) which Arch Toxicol (2000) 74: 85±91 Ó Springer-Verlag 2000”
BackgroundMethodInfluentialWarnasuriya, G. D., Elcombe, B. M., Foster, J. R., & Elcombe, C. R. (2010) · Archives of Toxicology · doi:10.1007/s00204-009-0489-9 · Cited by 78
“Peroxisome proliferators modulate gene expression by activating an intracellular receptor, the peroxisome proliferator-activated receptor ( Issemann and Green 1990 ) which recognises a specific peroxisome proliferator response element in selected genes leading to an immediate induction of gene expression.”
BackgroundKim, H. J., Ham, S. A., Kim, S. U., Hwang, J.-Y., Kim, J.-H., Chang, K. C., Yabe-Nishimura, C., Kim, J.-H., & Seo, H. G. (2008) · Circulation Research · doi:10.1161/circresaha.107.158477 · Cited by 77
de Oliveira, A. C. P., Bertollo, C. M., Rocha, L. T. S., Junior, E. B. D. N., Costa, K. A., & Coelho, M. M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.026 · Cited by 85
Yang, C. H., Dharancy, S., Malapel, M., & Desreumaux, P. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i48.7591 · Cited by 78
Repression of IFN-γ Expression by Peroxisome Proliferator-Activated Receptor γ
Cunard, R., Eto, Y., Muljadi, J. T., Glass, C. K., Kelly, C. J., & Ricote, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7530 · Cited by 77
Polyunsaturated fatty acid regulation of hepatic gene transcription
Clarke, S. D., & Jump, D. Β. (1996) · Lipids · doi:10.1007/bf02637044 · Cited by 78
“Collectively, these data led many investigators to suggest that PPAR is the trans-factor responsible for mediating the fatty acid regulation of gene transcription (39, 44-50 ).”
BackgroundInfluentialPolyunsaturated fatty acids stimulate hepatic UCP-2 expression via a PPARα-mediated pathway
Armstrong, M. B., & Towle, H. C. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1197 · Cited by 78
“PPARa is expressed mainly in liver, kidney, intestinal mucosa, and brown adipose tissue, all tissues that are known to have high catabolic rates for fatty acids (5, 18).”
BackgroundTRANSCRIPTIONAL ACTIVATION OF CYTOCHROME P450 GENES BY DIFFERENT CLASSES OF CHEMICAL INDUCERS
Dogra, S. C., Whitelaw, M. L., & May, B. K. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02135.x · Cited by 86
The biochemistry and physiology of long-chain dicarboxylic acid metabolism
Ranea‐Robles, P., & Houten, S. M. (2023) · Biochemical Journal · doi:10.1042/bcj20230041 · Cited by 81
The effect of di-2-ethylhexyl phthalate on inflammation and lipid metabolic disorder in rats
Zhou, L., Chen, H., Xu, Q., Han, X., Zhao, Y., Song, X., Zhao, T., & Lin, Y. (2018) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2018.12.009 · Cited by 78
Houston, K. D., Copland, J. A., Broaddus, R. R., Gottardis, M. M., Fischer, S. M., & Walker, C. L. (2003) · PubMed · Cited by 77
Jiang, W. G., Redfern, A., Bryce, R. P., & Mansel, R. E. (2000) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.1999.0131 · Cited by 82
Qi, C., Zhu, Y., Pan, J., Yeldandi, A. V., Rao, M. S., Maeda, N., Subbarao, V., Pulikuri, S., Hashimoto, T., & Reddy, J. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1585 · Cited by 77
Emerging roles of mitochondria in the evolution, biogenesis, and function of peroxisomes
Mohanty, A., & McBride, H. M. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00268 · Cited by 76
Metadata
- Authors
- Issemann, I., & Green, S.
- Venue
- Nature
- Published
- 1990-10
- Volume
- 347
- Issue
- 6294
- Pages
- 645-650
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2066092624
- Cited by
- 3,519
- References
- 56
- Citations by year
- 2026: 38 · 2025: 59 · 2024: 60 · 2023: 47 · 2022: 58 · 2021: 71 · 2020: 63 · 2019: 82 · 2018: 74 · 2017: 90 · 2016: 87 · 2015: 94 · 2014: 98 · 2013: 106 · 2012: 133
- FWCI
- 25.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- peroxisome proliferator-activated receptors, steroid hormone receptors, ligand-activated transcription factors, peroxisome proliferation, hepatocarcinogens, hypolipidemic effect, cancer risk, receptor cloning
- MeSH terms
- Amino Acid Sequence, Animals, Hypolipidemic Agents, Base Sequence, Binding Sites, Cloning, Molecular, DNA, Humans, Liver, Liver Neoplasms, Experimental, Microbodies, Molecular Sequence Data, Nafenopin, Receptors, Estrogen, Receptors, Glucocorticoid, Receptors, Steroid, Sequence Homology, Nucleic Acid, Tissue Distribution, Gene Expression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.